◆ 会议时间：2021年11月12-15日
◆ 会议地点：虚拟会议（）

◆ 会议简介：

2021年第72届美国肝病研究协会(AASLD)年会将于2021年11月12-15日以虚拟数字会议形式举行。美国肝病年会(The Liver Meeting)是目前世界上最大、最具权威的肝脏病学会议，每年都有来自世界各地的9000余名肝病学家和从事肝病研究的专业人士前来参会，一起分享探讨肝病学领域的突破性研究成果、新的治疗指南以及最新的治疗进展。

美国肝病研究学会（AASLD）成立于1950年，是全球领先的由致力于预防和治疗肝脏疾病的科学家和相关专业人士组成的国际性组织，现在世界各地拥有超过5200名会员，包括肝脏病学家、外科医生、科学家和其他卫生保健专业人员等。AASLD通过教育会议、培训计划、专业出版物宣以及与政府机构和姐妹社团的合作，推进肝病学的科学和实践，改善患者的护理质量，为数百万肝病患者提供科学的治疗方案。AASLD的愿景是预防和治愈肝脏疾病（未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网lingyuint.com）。

The Liver Meeting® 2021 - The 72nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

WHO ATTENDS THE LIVER MEETING

The Liver Meeting® brings together attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field. Our attendees include those focused on:

• Adult and pediatric hepatology
• Clinical, basic and translational researchers
• Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, pathologists, anesthesiologists and radiologists
• Primary care physicians
• NPs, PAs, RNs, pharmacists and other allied health professionals
• Trainees and students in all disciplines listed above

摘要提交重要日期：

2021 Abstract Submission Dates

• Regular Abstract Submission Opens: April 1, 2021
• Regular Abstract Submission Closes: June 18, 2021
• Abstract Notifications Sent: August 16 2021
• Late-breaking Abstract Submission Opens: September 8, 2021
• Late-breaking Abstract Submission Closes: September 15, 2021

点此提交摘要>>>Submit Abstract>>>

摘要提交说明：

• Abstracts must be received by 11:59 pm ET, Friday, June 18, 2021 to be considered for review.
• Abstracts received after the deadline will not be accepted and incomplete abstracts will be considered ineligible for inclusion.
• Abstracts must be submitted online through the abstract submission site. No faxed copies, discs, thumb drives or email submissions will be accepted.
• An abstract may only be submitted to The Liver Meeting® once. Duplicate abstracts (reporting the same data) that are submitted under a different author will be administratively withdrawn.
• 提交费：To submit an abstract, there is a nonrefundable fee of $70. Authors can pay by VISA®, MasterCard®, American Express® or DISCOVER®; your credit card will be processed by AASLD. Please be sure to list the current expiration date of your credit card.
• Abstracts will not be considered for publication and/or presentation unless payment is provided before the submission deadline. No checks or purchase orders will be accepted.
• Case reports, or novel clinical observations can provide new insight into clinical phenotypes or pathogenesis of disease. Case reports are not frequently submitted to The Liver Meeting® but authors who so choose may submit one using the same guidelines outlined below for standard abstract submission. Case reports will be scored and ranked by the same review team that scores abstract submissions for the category and descriptor selected by the submitting author.

AASLD 2021 注册费（会议费）

点此查看注册费>>>

AASLD is no longer hosting an in-person component in Anaheim. The Liver Meeting ® 2021 will be conducted through The Liver Meeting Digital Experience™ (TLMdX®). In-person registration costs will be refunded for those who have already registered.

What does registration for TLMdX® include?

The Liver Meeting Digital Experience™ will provide a forum for the exchange of groundbreaking basic, translational, and clinical research in diseases of the liver and biliary tract, and in liver transplantation. This digital experience will create an arena for the presentation and interchange of opinions on state-of-the-art care and management of the full spectrum of patients with liver disease.

The Liver Meeting Digital Experience™ includes access to:

• Flagship Programs of The Liver Meeting: Postgraduate Course and Basic Science Symposium
• ePoster Content
• Live Educational Content
• Live Abstract Content
• OnDemand Educational Content
• A Myriad of Networking Opportunities
• And much, much, more!

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。